MetLife, Inc.

(New York Stock Exchange)
Back to all articles
Bullish +75

MetLife stock gets a USD 115 Buy target from Jefferies

Analyst upgrade AI-generated analysis

πŸ“ˆ Jefferies maintained a Buy rating on MetLife and set a new price target of USD 115.00, which is 21.8 percent above the current stock price.

πŸ’° Q2 adjusted earnings per share rose 20 percent year-over-year to USD 2.43, driven by strong operational performance.

πŸ“Š Adjusted return on equity reached 17.0 percent in the second quarter, hitting the top end of MetLife's annual target range of 15 percent to 17 percent.

πŸ’΅ Premiums, fees, and other revenues grew 7 percent to USD 13.7 billion during the quarter ended September 30, 2026.

πŸ“ˆ The company estimated at least USD 600 million in pre-tax variable investment income for the third quarter, covering private equity and real estate funds.

🀝 Analyst consensus remains bullish with a Buy rating from 12 analysts and an average price target of USD 104.31.

πŸ“‰ MetLife stock traded at USD 94.43 on October 2, 2026, sitting 6.44 percent below its 52-week high of USD 100.93.

🏦 The company's market capitalization stood at USD 60.8 billion as of the latest trading session.

πŸ“… MetLife is scheduled to release its third-quarter earnings report and financial supplement on November 4, 2026.

πŸ”„ Piper Sandler previously raised its price target from USD 99.00 to USD 110.00 in late September, contributing to the positive analyst sentiment.

Bullish Signals
  • MetLife adjusted Q2 EPS rose 20 percent to USD 2.43, demonstrating strong earnings growth.
  • Adjusted return on equity reached 17.0 percent, hitting the top of MetLife's annual target range of 15 percent to 17 percent.
  • Premiums, fees, and other revenues grew 7 percent year-over-year to USD 13.7 billion in Q2 2026.
  • Analyst consensus remains bullish with a Buy rating from 12 analysts and an average price target of USD 104.31, which is 10.46 percent above the current stock price.
  • Jefferies maintained its Buy rating and set a USD 115.00 price target on October 1, 2026, signaling continued confidence in the company's performance.
  • Piper Sandler raised its price target from USD 99.00 to USD 110.00 on September 22, 2026, further supporting the positive analyst sentiment.
Full Analysis
MetLife Inc. received a USD 115 price target from Jefferies on October 1, 2026, maintaining its Buy rating for the stock. This new target represents a 21.8 percent premium over MetLife's trading price of USD 94.43 as of October 2, 2026. The analyst decision follows Piper Sandler's recent upgrade in late September, which raised its target from USD 99.00 to USD 110.00, contributing to a current consensus Buy rating among 12 analysts with an average price target of USD 104.31. MetLife reported strong second-quarter results that support the bullish analyst sentiment. Adjusted earnings per share rose 20 percent year-over-year to USD 2.43, while adjusted net income increased 15 percent to USD 1.6 billion. The company achieved an adjusted return on equity of 17.0 percent, hitting the top end of its annual target range between 15 percent and 17 percent. Revenue driven by premiums, fees, and other sources grew 7 percent to USD 13.7 billion for the quarter. Looking ahead to the third quarter ended September 30, 2026, MetLife estimates pre-tax variable investment income of at least USD 600 million, covering private equity, real estate, and other funds along with prepayment fees. The company is scheduled to release its final Q3 earnings report and financial supplement on November 4, 2026, which will provide a definitive update on these preliminary estimates. As of October 2, 2026, MetLife's stock traded at USD 94.43, sitting 6.44 percent below its 52-week high of USD 100.93 with a market capitalization of USD 60.8 billion.